Walter & Keenan Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Walter & Keenan Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-12,200	Closed	-$561K	–	148
2016 Q3	$561K	Buy	12,200 +2,000	+20%	+$104K	0.31%	74
2016 Q2	$512K	Hold	10,200	–	–	0.29%	82
2016 Q1	$546K	Buy	10,200 +2,200	+28%	+$129K	0.31%	79
2015 Q4	$525K	Hold	8,000	–	–	0.31%	74
2015 Q3	$452K	Hold	8,000	–	–	0.28%	84
2015 Q2	$473K	Buy	8,000 +1,000	+14%	+$61.7K	0.27%	85
2015 Q1	$436K	Hold	7,000	–	–	0.25%	96
2014 Q4	$403K	Buy	7,000 +2,000	+40%	+$111K	0.23%	94
2014 Q3	$269K	Buy	+5,000	New	+$265K	0.16%	119

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Walter & Keenan Wealth Management's TEVA Position: Q4 2016 in Review

Walter & Keenan Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 12,200 shares — an estimated $561K sold.

Walter & Keenan Wealth Management first reported a position in TEVA in Q3 2014 and held it in 9 quarters. The position peaked at $561K in Q3 2016. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Walter & Keenan Wealth Management reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Walter & Keenan Wealth Management sold 12,200 Teva Pharmaceuticals shares in Q4 2016, an estimated $561K.
Walter & Keenan Wealth Management first reported a position in Teva Pharmaceuticals in Q3 2014 and held it in 9 quarters.
Walter & Keenan Wealth Management's Teva Pharmaceuticals position peaked at $561K in Q3 2016.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Walter & Keenan Wealth Management's 13F filing for Q4 2016, filed 2 Feb 2017.